Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Offering a robust, cloud-centric platform, comprehensive longitudinal electronic health record (EHR) data, and advanced analytical tools, this system assists healthcare providers and life sciences organizations in discovering new relationships among previously isolated healthcare information. It comprises a suite of software-as-a-service (SaaS) applications that facilitate swift population management, performance evaluation, and meaningful engagement with both patients and providers. This solution allows healthcare organizations to gather, link, and merge information from numerous varied sources across their entire enterprise and clinically integrated networks. It empowers designers of care and quality programs to effectively search and explore populations related to diagnoses, treatments, outcomes, costs, and demographics. Furthermore, it swiftly pinpoints target populations, enabling improved decision-making regarding risk-stratified care management. Additionally, it presents an integrated framework that correlates vast amounts of clinical, operational, and financial events into benchmarks and scorecards for insightful comparisons, ultimately enhancing the overall quality of care delivered. This comprehensive approach not only streamlines data integration but also supports innovative healthcare solutions.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
API Access
Has API
Integrations
Signals Research Suite
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
IBM
Founded
1911
Country
United States
Website
www.ibm.com/watson-health/about/explorys
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/
Product Features
Electronic Medical Records (EMR)
Appointment Management
Charting
Compliance Tracking
E-Prescribing
E/M Coding
HIPAA Compliant
Handwriting Recognition
Integrated Telehealth
MIPS Certified
Meaningful Use Certified
ONC-ATCB Certified
Patient Portal
Self Service Portal
Voice Recognition